Cambridge Healthtech Institute’s Inaugural

Immunotherapy for COVID-19

Vaccine and Biotherapeutic Development for SARS-CoV-2

October 8, 2020


In response to the urgent need for vaccines and biotherapeutics for the novel coronavirus, Cambridge Healthtech Institute is adding a new track dedicated to COVID-19 to our Immuno-Oncology Summit that aims to facilitate innovation and collaboration in immunotherapy approaches to control the cytokine storm, develop novel antibody biotherapeutics and vaccines, and understand the immune response mechanisms.






Speaker Proposal